90 studies found for:    Open Studies | "Anemia, Aplastic"
Show Display Options
Rank Status Study
21 Unknown  Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.
Condition: Aplastic Anemia
Intervention: Biological: bone marrow derived mesenchymal stem cells
22 Not yet recruiting ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Rabbit ATG, (Genzyme);   Drug: Cy;   Drug: CsA;   Biological: Cord blood
23 Not yet recruiting Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload
Conditions: Aplastic Anemia;   Dysmyelopoietic Syndromes;   Iron Overload
Intervention:
24 Recruiting Extended Dosing With Eltrombopag for Severe Aplastic Anemia
Condition: Severe Aplastic Anemia (SAA)
Intervention: Drug: Eltrombopag
25 Unknown  Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)
Condition: Aplastic Anemia
Intervention: Drug: Cyclophosphamide, Fludarabine, Thymoglobulin
26 Unknown  Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Intervention: Drug: ATG
27 Recruiting Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome
Conditions: Aplastic Anemia;   Hypoplastic Myelodysplastic Syndrome
Interventions: Drug: BL-8040;   Drug: horse anti-thymocyte globulin (hATG);   Drug: Methylprednisolone;   Drug: Cyclosporine
28 Not yet recruiting Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Drug: Rabbit ATG
29 Recruiting Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia;   Bone Marrow Failure Syndromes
Interventions: Procedure: Bone marrow transplant;   Drug: Thymoglobulin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: TBI;   Drug: Mesna;   Drug: Tacrolimus;   Drug: Mycophenolic acid mofetil
30 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Other: Human umbilical cord-derived MSCs and cyclosporin A;   Other: cyclosporin A
31 Recruiting hATG+CsA vs hATG+CsA+Eltrombopag for SAA
Condition: Severe Aplastic Anemia
Interventions: Drug: hATG;   Drug: CsA;   Drug: Eltrombopag
32 Unknown  Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia
Conditions: Haematological Malignancies;   Acquired Aplastic Anaemia
Intervention:
33 Recruiting Randomised Study Comparing Different Dosages of Rabbit ATG in Patients With SAA
Condition: Acquired Aplastic Anemia.
Intervention: Drug: Thymoglobulin
34 Recruiting Nandrolone Decanoate in the Treatment of Telomeropathies
Conditions: Aplastic Anemia;   Bone Marrow Failure Syndromes;   Idiopathic Pulmonary Fibrosis;   Telomere Shortening
Intervention: Drug: Nandrolone Decanoate
35 Recruiting Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
Conditions: Dyskeratosis Congenita;   Hoyeraal Hreidarsson Syndrome;   Revesz Syndrome;   Aplastic Anemia
Interventions: Biological: alemtuzumab;   Drug: Fludarabine;   Drug: Cyclosporins;   Drug: Mycophenolate mofetil
36 Recruiting Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis
Conditions: Leukemia;   Lymphoma;   Myelodysplastic Syndrome;   Myelofibrosis;   Severe Aplastic Anemia;   Allogeneic Transplant
Intervention: Drug: Cyclophosphamide
37 Recruiting CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Conditions: Bone Marrow Failure Syndrome;   Severe Aplastic Anemia;   Severe Congenital Neutropenia;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Schwachman Diamond Syndrome;   Primary Immunodeficiency Syndromes;   Acquired Immunodeficiency Syndromes;   Histiocytic Syndrome;   Familial Hemophagocytic Lymphocytosis;   Lymphohistiocytosis;   Macrophage Activation Syndrome;   Langerhans Cell Histiocytosis (LCH);   Hemoglobinopathies;   Sickle Cell Disease;   Sickle Cell-beta-thalassemia
Intervention: Biological: CD34 Stem Cell Selection Therapy
38 Recruiting Cord Blood Transplant
Conditions: Chronic Myelogenous Leukemia (CML);   Acute Myelogenous Leukemia (AML);   Myelodysplastic Syndrome;   Multiple Myeloma;   Hodgkin Lymphoma;   Non-Hodgkin Lymphoma;   Chronic Lymphocytic Leukemia (CLL);   Acute Lymphocytic Leukemia (ALL);   Severe Aplastic Anemia
Intervention: Genetic: umbilical cord transplant (UCB)
39 Unknown  Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure
Condition: Nonmalignant Neoplasm
Interventions: Biological: alemtuzumab;   Drug: cyclosporine
40 Recruiting Horse ATG in Patients With Aplastic Anemia (AA) or Low/Int-1 Risk Myelodysplastic Syndrome (MDS)
Condition: Leukemia
Interventions: Drug: hATG;   Drug: Cyclosporine;   Drug: Methylprednisone;   Drug: Pegfilgrastim;   Drug: Filgrastim

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years